Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT

Matthias Eiber, Ken Herrmann, Jérémie Calais et al. · Journal of Nuclear Medicine · 2017 · 611 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The Template of the Primary Lymphatic Landing Sites of the Prostate Should Be Revisited: Results of a Multimodality Mapping Study

Agostino Mattei, Frank G. Fuechsel, Nivedita Dhar et al. · European Urology · 2007 · 452 citations

Medicine, Oncology, Urology +13

RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer

C.A. Lawton, Jeff M. Michalski, Issam El Naqa et al. · International Journal of Radiation Oncology*Biology*Physics · 2008 · 413 citations · Full text

Medicine, Radiation Oncology, Urology +14

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Paul Sargos, Sylvie Chabaud, I. Latorzeff et al. · The Lancet Oncology · 2020 · 322 citations · Full text

Medicine, Oncology, Urology +17

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Stephen J. Freedland, Murilo Luz, Ugo De Giorgi et al. · New England Journal of Medicine · 2023 · 291 citations

Pharmacy, Pharmacology, Pharmacotherapy +15